现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2015年
13期
1874-1878
,共5页
高文华%付勇%谷翠华%卢宁
高文華%付勇%穀翠華%盧寧
고문화%부용%곡취화%로저
胃癌%EGFR%CEA%P53
胃癌%EGFR%CEA%P53
위암%EGFR%CEA%P53
gastric cancer%EGFR%CEA%P53
目的:探讨EGFR、CEA和P53在胃癌组织中的表达与临床病理特征之间的关系,并分析其临床意义。方法:应用免疫组织化学方法检测90例胃癌组织中EGFR、CEA和P53的表达,分析EGFR、CEA和P53的表达与临床病理特征的关系。并对64例中晚期胃癌患者进行生存分析。结果:90例胃癌组织标本中EG-FR、CEA和P53阳性表达率分别为45.6%、74.4%和53.3%。EGFR的表达与胃癌的分化程度、浸润深度、淋巴结转移和病理分期密切相关( P<0.05);CEA阳性表达与胃癌的浸润深度、淋巴结转移密切相关( P<0.05);P53蛋白表达与胃癌的浸润深度、淋巴结转移和病理分期密切相关( P<0.05)。EGFR、CEA的高表达与患者术后生存期<3年相关(均P<0.05)。EGFR的表达与CEA和P53均呈正相关( r=0.280,P=0.008;r=0.230,P=0.030)。单因素分析显示EGFR、CEA和P53均为影响中晚期胃癌患者预后的重要因素,多因素分析表明EGFR和CEA是影响中晚期胃癌患者预后的独立危险因素。结论:联合检测EGFR、CEA和P53在胃癌组织中的表达有助于胃癌的临床诊断、治疗及预后评估。
目的:探討EGFR、CEA和P53在胃癌組織中的錶達與臨床病理特徵之間的關繫,併分析其臨床意義。方法:應用免疫組織化學方法檢測90例胃癌組織中EGFR、CEA和P53的錶達,分析EGFR、CEA和P53的錶達與臨床病理特徵的關繫。併對64例中晚期胃癌患者進行生存分析。結果:90例胃癌組織標本中EG-FR、CEA和P53暘性錶達率分彆為45.6%、74.4%和53.3%。EGFR的錶達與胃癌的分化程度、浸潤深度、淋巴結轉移和病理分期密切相關( P<0.05);CEA暘性錶達與胃癌的浸潤深度、淋巴結轉移密切相關( P<0.05);P53蛋白錶達與胃癌的浸潤深度、淋巴結轉移和病理分期密切相關( P<0.05)。EGFR、CEA的高錶達與患者術後生存期<3年相關(均P<0.05)。EGFR的錶達與CEA和P53均呈正相關( r=0.280,P=0.008;r=0.230,P=0.030)。單因素分析顯示EGFR、CEA和P53均為影響中晚期胃癌患者預後的重要因素,多因素分析錶明EGFR和CEA是影響中晚期胃癌患者預後的獨立危險因素。結論:聯閤檢測EGFR、CEA和P53在胃癌組織中的錶達有助于胃癌的臨床診斷、治療及預後評估。
목적:탐토EGFR、CEA화P53재위암조직중적표체여림상병리특정지간적관계,병분석기림상의의。방법:응용면역조직화학방법검측90례위암조직중EGFR、CEA화P53적표체,분석EGFR、CEA화P53적표체여림상병리특정적관계。병대64례중만기위암환자진행생존분석。결과:90례위암조직표본중EG-FR、CEA화P53양성표체솔분별위45.6%、74.4%화53.3%。EGFR적표체여위암적분화정도、침윤심도、림파결전이화병리분기밀절상관( P<0.05);CEA양성표체여위암적침윤심도、림파결전이밀절상관( P<0.05);P53단백표체여위암적침윤심도、림파결전이화병리분기밀절상관( P<0.05)。EGFR、CEA적고표체여환자술후생존기<3년상관(균P<0.05)。EGFR적표체여CEA화P53균정정상관( r=0.280,P=0.008;r=0.230,P=0.030)。단인소분석현시EGFR、CEA화P53균위영향중만기위암환자예후적중요인소,다인소분석표명EGFR화CEA시영향중만기위암환자예후적독립위험인소。결론:연합검측EGFR、CEA화P53재위암조직중적표체유조우위암적림상진단、치료급예후평고。
Objective:To investigate the clinical value of the exPression of EGFR,CEA and P53 in clinical diagno-sis,treatment and Prognosis in gastric cancer Patients. Methods:The exPression of EGFR,CEA and P53 was detected by immunohistochemical method in samPles of 90 gastric cancers,and analyze the relationshiP of EGFR,CEA and P53 exPression in gastric cancer and clinical features of gastric cancer. 64 cases of Patients with middle-late gastric canc-er were included for survival analysis. Results:The Positive exPression rates of EGFR,CEA and P53 in gastric cancer were 45. 6%,74. 4%,53. 3%. EGFR exPression was significantly correlated with differentiation degree,infiltrative dePth,lymPhatic metastasis and clinicoPathological stage(P<0. 05). The Positive exPression of CEA was related to the dePth of invasion and lymPhatic metastasis(P<0. 05). P53 exPression was significantly correlated with infiltrative dePth,lymPhatic metastasis and clinicoPathological stage(P<0. 05). The EGFR and CEA exPression in gastric canc-er were associated with the survival stage less than three years(all P<0. 05). EGFR exPression was Positively corre-lated with CEA and P53(r=0. 280,P=0. 008 and r=0. 230,P=0. 030). Univariate analysis showed that EGFR, CEA and P53 were the most imPortant indicators in Prognosis of middle-late gastric cancer. But multivariate analysis revealed that EGFR and CEA were indePendent Prognostic factors for gastric cancer with middle-late stage. Conclu-sion:Combined detection of the exPression of EGFR,CEA and P53 in gastric cancer contributes to the clinical diagno-sis,treatment and Prognosis.